MedPath
FDA Approval

Sildenafil

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
December 3, 2019
Labeling Type
Human Prescription Drug Label
Sildenafil(20 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

CALVIN, SCOTT AND COMPANY, INCORPORATED

CALVIN, SCOTT AND COMPANY, INCORPORATED

CALVIN, SCOTT AND COMPANY, INCORPORATED

073404626

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sildenafil

Product Details

NDC Product Code
17224-460
Application Number
ANDA203814
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 3, 2019
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
TRIACETINInactive
Code: XHX3C3X673Class: IACT
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Code: O7TSZ97GEPClass: IACT
Code: BW9B0ZE037Class: ACTIMQuantity: 20 mg in 1 1
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
© Copyright 2025. All Rights Reserved by MedPath